The most commonly used and prescribed birth control pill in the U.S. was classified by the International Agency for Research on Cancer (IARC) at the World Health Organization (WHO) as carcinogenic. In ...

A molecular switch that “supercharges” sperm could inspire new safe methods of contraception—including a non-hormonal male birth control pill—and improved infertility treatments. This is the discovery ...

GRACE AIGNER: Hi everyone! I’m Grace Aigner from the Minnesota Daily. Welcome back to another episode of In The Know, a podcast dedicated to the University of Minnesota. In my last episode, we talked ...

A major discovery has paved the way for a male contraceptive pill, say scientists. The molecular “switch” that "supercharges" sperm for their final sprint to an egg has been pinpointed by American ...

In the Balbach lab, researchers like graduate student Macy Jenks (R) are helping push the boundaries of reproductive metabolism. (Finn Gomez & Paul Henderson via SWNS) By Stephen Beech A major ...

1 in 4 sexually active women has used injectable birth control, administered into the muscle by a clinician, but many may be unaware of its association with meningioma, the most common brain tumor in ...

The layoffs have raised fears that the administration could be effectively ending an initiative that provides contraception for millions of low-income women. By Caroline Kitchener Reporting from ...

Women who use Depo-Provera face a higher risk of developing a slow-growing brain tumor, according to a new study that comes as the contraceptive’s maker, Pfizer, faces hundreds of lawsuits claiming ...

WASHINGTON — The Trump administration has targeted a federal office that oversees a $300 million family planning program for layoffs, raising fears that it is effectively ending an initiative that ...

ATLANTA - Femasys Inc. (NASDAQ:FEMY), a $27.5 million market cap medical device company whose stock has surged nearly 28% in the past week, has initiated a post-market surveillance clinical study for ...